43 /100
MEDIUM RISK
Score updated Jun 27, 2026

LMED — LataMed AI Corp. Dilution Risk Tracker

Track LMED dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track LMED — Get alerts when the score changes →

As of June 27, 2026, LataMed AI Corp. (LMED) has a DilutionWatch DilutionScore of 43/100, rated MEDIUM dilution risk. LataMed AI Corp. has a market capitalization of $128.55M, 56.13M shares outstanding.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
40
📊 Float Risk
57
⚠️ Warrant Exposure
40
🔄Convertible Debt—

🌦️ Dilution Forecast

⛅
Watch
Minor dilution signals detected
15%
🔄 Reverse Split 30%
• 50-day avg $1.87 approaching $1 threshold
🔔 Track LMED — Get forecast alerts →

💹 Market Data

Market Cap$128.55M
Shares Outstanding56.13M
Float16.13M
CashN/A
Debt$423.3K
Short InterestN/A

🏛 Institutional Holdings

Institutional data not yet available.

📉 Short Interest

Short Interest106.3K
Days to Cover1.0
% of Float0.7%
FINRA data as of Jun 15, 2026

📁 Recent SEC Activity

No recent SEC insights

📰 Recent News

No recent news
Track LMED Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking LMED — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

AAT ACH AHRT ALOT AMPH

Browse all 7,800+ tracked stocks →

🔬 More Research for LMED
📊 LMED FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 LMED Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.